$NSPR
InspireMD, Inc.
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$0.500
▼-4.80%-$0.025
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInspireMD, Inc.
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is NSPR down today? It is at $0.500 (-4.80%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NSPR spikes, and full due diligence on NSPR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NSPR 1 time in the last 30 days. Create a free account to track $NSPR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NSPR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NSPR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAnnounces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 MillionReported 50% of the shares underlying the participating holders' Series J Warrants and all of the shares underlying the participating holders'Reported Series K Warrants to modify (i) the exercise price to $0.7674 per share, representing the Nasdaq Official Closing Price of the Company'sReported exercise price and termination date with respect to the other 50% of the shares underlying the participating holders' Series J, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 23, 2026 · 14 days agoAcross every filing on file, supply equal to 382.1% of the tradeable float is in play - 382.1% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
47,169,811 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $75.0M in size · Priced at $1.59/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Stuka Paul Director | Bought (open market) | +20K 0.04% of company | added 3.1% | 668K | $18K at $0.880 | May 27, 26 |
Gleason Shane Thomas Officer | Sold (automatic/other) | -23K 0.05% of company | sold 2.1% | 1.05M | $23K at $1.01 | May 19, 26 |
Stuka Paul Director | Bought (open market) | +5K 0.01% of company | added 0.8% | 648K | $6K at $1.15 | May 14, 26 |
Stuka Paul Director | Bought (open market) | +10K 0.02% of company | added 1.6% | 643K | $12K at $1.16 | May 13, 26 |
Slosman Marvin Officer | Bought (open market) | +21K 0.05% of company | added 0.6% | 3.56M | $25K at $1.20 | May 12, 26 |
Stuka Paul Director | Bought (open market) | +10K 0.02% of company | added 1.6% | 633K | $12K at $1.19 | May 11, 26 |
Stuka Paul Director | Bought (open market) | +66K 0.1% of company | added 12% | 623K | $76K at $1.16 | May 8, 26 |
Roubin Gary S Director | Bought (open market) | +90K 0.2% of company | added 12% | 834K | $106K at $1.18 | May 7, 26 |
Stuka Paul Director | Bought (open market) | +6K 0.01% of company | added 1.2% | 532K | $7K at $1.15 | May 7, 26 |
Ward Scott R. Director | Bought (open market) | +73K 0.2% of company | added 45% | 237K | $84K at $1.15 | May 7, 26 |
Stuka Paul Director | Bought (open market) | +2K | added 0.3% | 525K | $2K at $1.12 | May 6, 26 |
Ward Scott R. Director | Bought (open market) | +16K 0.03% of company | added 11% | 164K | $18K at $1.15 | May 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on NSPR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NSPR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NSPR last traded at $0.500, down 4.80% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
InspireMD, Inc. (NSPR) is next expected to report earnings on Tuesday, November 3, 2026, about 27 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NSPR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NSPR 1 time in the last 30 days.
NSPR (InspireMD, Inc.) trades on XNAS, with a market cap of about $24M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NSPR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NSPR discussion
Sign in to ask a question or join the discussion.